Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy Integrated Research shares
Own Integrated Research shares in just a few minutes.
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Integrated Research Limited is a software-application business based in Australia. Integrated Research shares (IRI) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Integrated Research has a trailing 12-month revenue of around $91.8 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Integrated Research
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Integrated Research . Find the share by name or ticker symbol: IRI. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Integrated Research reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Integrated Research . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
What's in this guide?
- Integrated Research key stats
- Compare share trading platforms
- Is Integrated Research stock a buy or sell?
- Integrated Research performance over time
- Are Integrated Research shares over-valued?
- Integrated Research 's financials
- How volatile are Integrated Research shares?
- Does Integrated Research pay a dividend?
- Other common questions
Integrated Research share price
Use our graph to track the performance of IRI stocks over time.Integrated Research shares at a glance
Information last updated 2021-06-17.
| 52-week range | $1.92 - $4.8767 |
|---|---|
| 50-day moving average | $2.2661 |
| 200-day moving average | $2.5101 |
| Target price | $2.6 |
| PE ratio | 26.6667 |
| Dividend yield | $0.037 (1.86%) |
| Earnings per share (TTM) | $0.072 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Integrated Research stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Integrated Research price performance over time
Historical closes compared with the last close of A$2.17
| 1 week (2021-06-16) | 9.05% |
|---|---|
| 1 month (2021-05-21) | -6.06% |
| 3 months (2021-03-23) | -5.24% |
| 6 months (2020-12-23) | -26.94% |
| 1 year (2020-06-23) | -38.87% |
|---|---|
| 2 years (2019-06-21) | -36.73% |
| 3 years (2018-06-22) | -31.11% |
| 5 years (2016-06-23) | -5.65% |
Is Integrated Research under- or over-valued?
Valuing Integrated Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integrated Research 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Integrated Research 's P/E ratio
Integrated Research 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Integrated Research shares trade at around 27x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Integrated Research 's EBITDA
Integrated Research 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.6 million.
The EBITDA is a measure of a Integrated Research 's overall financial performance and is widely used to measure a its profitability.
Integrated Research financials
| Revenue TTM | $91.8 million |
|---|---|
| Operating margin TTM | 20.95% |
| Gross profit TTM | $110.9 million |
| Return on assets TTM | 9.42% |
| Return on equity TTM | 16.42% |
| Profit margin | 13.46% |
| Book value | 0.434 |
| Market capitalisation | $330.7 million |
TTM: trailing 12 months
Integrated Research share dividends
Dividend payout ratio: 53.57% of net profits
Recently Integrated Research has paid out, on average, around 53.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Integrated Research shareholders could enjoy a 3.77% return on their shares, in the form of dividend payments. In Integrated Research 's case, that would currently equate to about A$0.037 per share.
Integrated Research 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 1 September 2020 (the "ex-dividend date").
Integrated Research share price volatility
Over the last 12 months, Integrated Research 's shares have ranged in value from as little as $1.92 up to $4.8767. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Integrated Research 's is 0.5793. This would suggest that Integrated Research 's shares are less volatile than average (for this exchange).
Integrated Research overview
Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, unified communication networks, and payment networks in the Americas, Europe, and the Asia Pacific. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications that run on these platforms. It also provides testing, maintenance, and software as a service solutions, as well as professional services. The company serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturing companies through sales offices, as well as through a distribution network. Integrated Research Limited was founded in 1988 and is based in North Sydney, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
Amazon Prime Day Australia 2021: All the best deals from Day 2
Here are all the best deals from Amazon Prime Day Australia's second day - including the return of dirt-cheap Nintendo Switch consoles.
-
Prime Day deal: $100 off Sony’s ‘Bose Killing’ Headphones
Get 33% off Sony WH1000XM3 Wireless Noise Cancelling Headphones during Amazon Prime Day 2021. Here's how to get the deal before it disappears.
-
How to get $120 off Nintendo Switch on Amazon Prime Day
Amazon Australia is selling the Nintendo Switch video game console for $349 during Prime Day - that's over $120 off the RRP.
-
Amazon Prime Day’s best deals on big-ticket items: Up to 46% off
From Segways to stand-up paddleboards, these are the best Prime Day savings on the most expensive items.
-
Nacon RIG 500 Pro HC Gen 2 review: Super comfortable gaming headphones
The Nacon Rig 500 Pro HC headphones have wide console and PC compatibility, Dolby Atmos licensing and a genuinely comfortable design, even for longer gaming sessions.
-
Oppo Find X3 Neo 5G review: Oppo’s better flagship phone
The Oppo Find X3 Neo lacks the utter flagship features of the Find X3 Pro, but you won't miss them, while you will enjoy its lower price point.
-
7 health insurance deals to save you money at tax time
Avoid the MLS tax and get a rebate by taking out health insurance. Here are 7 deals that’ll save you money on your tax returns.
-
Today’s ASX top stocks: Milton Corporation (MLT ↑16.0%), Oneview Healthcare (ONE ↑12.8%)
The 10 biggest movers on the ASX for Tuesday 22 June 2021.
-
Mobile plans are now more expensive, but here’s a hack to save $200 a year
Telstra, Optus and Vodafone keep raising their prices even as the rest of the market is more affordable than ever.
Ask an Expert
